Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
about
Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceA critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaEpigenetic modifications in cancerEpigenetic changes of DNA repair genes in cancerEpigenetics changes in cancer cellsO6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaA decade of exploring the cancer epigenome - biological and translational implicationsAn overview of epigenetics and chemopreventionPhase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaEpigenetics as a mechanism driving polygenic clinical drug resistanceComprehensive genomic characterization defines human glioblastoma genes and core pathwaysBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveMethylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylationRole of promoter hypermethylation in Cisplatin treatment response of male germ cell tumorsMethylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytomaCharacteristic promoter hypermethylation signatures in male germ cell tumorsFrequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcomeThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaThe clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerEpigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceMolecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and TreatmentO(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsEpigenetic epidemiology: promises for public health researchDNA methylation biomarkers: cancer and beyondModern brain tumor imagingFibronectin matrix assembly suppresses dispersal of glioblastoma cellsCIViC databaseMGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.Predictive value of CHFR and MLH1 methylation in human gastric cancer.The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysisSummary of emerging personalized medicine in neuroendocrine tumors: are we on track?Genome-wide epigenomic profiling for biomarker discoveryEpigenome-based personalized medicine in human cancerMultigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral bloodTransfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agentsBiomarkers in cancer staging, prognosis and treatment selectionTranslation in Data Mining to Advance Personalized Medicine for Health EquityMethylation matters
P2860
Q21261312-D76A668A-9DA5-4EE9-812E-EEE419611571Q21558626-3AEA94AA-9D4E-4A80-B41F-2D7C429A1C1FQ22242610-5008E3BD-61D3-478A-9282-EA87BC405A8EQ22242858-1D258680-F1F0-4245-A728-C63E69F8694EQ24548360-1727BBAF-9403-473E-A994-6B555D529A13Q24607903-A9349430-6F01-44AB-BE48-7FF0282E684EQ24612429-329C7174-70BE-458C-8363-5949F9D7EA08Q24614467-43B44B32-B4B9-403A-A3DE-CA1EE077358DQ24623823-0180A15D-18AC-4500-82D8-2628BA344042Q24644727-C65DF062-9001-4980-98E7-6ADBF8995156Q24651640-AE60669A-0F48-4C4F-9F06-4220A9710493Q24656128-2FBE3E4B-D0AD-4D15-90A1-9052D75048BEQ24658389-8D0F3169-7E1F-43BB-A55B-D1332CBFAD8CQ24682832-7FF0918B-25A1-4A65-ABE0-6CC6C773DD90Q24791749-6794C4F7-B016-4873-8BB5-7FBDDC16A445Q24795636-AE6DB33F-EAE5-404B-9DAE-6E2E8030F22BQ24799928-6041B85A-4195-4C6B-814A-4863F5CE83DBQ24800480-45268BCD-6BC4-4174-899E-F04B561AAA69Q26750641-0D0FA05B-CA24-447A-A821-1CF8EBEFF025Q26766285-8E0F5E43-860E-4088-B5B7-6280837B14D2Q26778761-44291D14-7408-4D05-B5B9-C65F88A744B8Q26785952-B7715549-F9B8-4520-8391-67E6CA5D9E39Q26853112-CF2612AD-5BB7-4A50-BD66-5A58A9272E31Q26853516-C9D5CEF7-EBD3-469E-8D5B-EE22DA846ECCQ26864455-FCBA1E9B-A2F8-428C-B23F-F8E8D41F69ACQ26996421-E0849CA8-F7EF-4443-86E3-F9FD597B3FE8Q27002344-A01CCB4B-D8AC-4AD8-B40D-D2E1093E5164Q27320106-DEC52CC2-70B9-4D1D-85DE-90CCF2283B3CQ27612411-AE41C7B7-28E3-4441-B7D3-75872E942FFEQ27851529-EEEB6A7F-BC68-4151-9286-8B74B39D9857Q27852998-8BD86C2E-57CA-4507-BE14-F9B3B3C5E172Q28074595-F81AAF4B-ABF0-4D03-8DB8-2247ACA36ECBQ28078610-28F72B91-C081-4B4E-BAB7-8137991211D7Q28080102-0F2765A9-3455-4B45-8BBF-1E6AFEDB84FDQ28083951-EB990893-224C-4839-AA6D-F5D6E2E271DCQ28255059-63A240FA-3576-4090-9F60-D49D7112D401Q28273012-77A39127-D07C-4C21-9B4C-9F253EDE5153Q28278305-6A96B534-9613-40A3-9E4B-E619E7EADB0DQ28315527-31A1FABC-B11F-4062-A939-215B67CEA304Q28364163-6191B0E9-3659-4341-A038-3F9CFD27181E
P2860
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@ast
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@en
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@nl
type
label
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@ast
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@en
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@nl
prefLabel
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@ast
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@en
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@nl
P2093
P3181
P1476
Inactivation of the DNA-repair ...... gliomas to alkylating agents.
@en
P2093
J G Herman
J Garcia-Foncillas
O F Hidalgo
S B Baylin
S N Goodman
V Vanaclocha
P304
P3181
P356
10.1056/NEJM200011093431901
P407
P577
2000-11-09T00:00:00Z